TEVA 5907 TEVA 5907 (Mesalamine Delayed-Release 400 mg)
Pill with imprint TEVA 5907 TEVA 5907 is Clear, Capsule-shape and has been identified as Mesalamine Delayed-Release 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative proctitis; ulcerative colitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 5907 TEVA 5907
Mesalamine Delayed-Release
- Imprint
- TEVA 5907 TEVA 5907
- Strength
- 400 mg
- Color
- Clear
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- 5-aminosalicylates
- Pregnancy Category
- B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-5907
More about mesalamine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 352 Reviews
- Drug class: 5-aminosalicylates
Consumer resources
- Patient Information
- Mesalamine rectal
- Mesalamine (Advanced Reading)
- Mesalamine Rectal (Advanced Reading)
- Other brands
- Lialda, Apriso, Asacol, Pentasa, ... +7 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.